|本期目录/Table of Contents|

[1]王大强.口服联合静脉补液对冠状动脉介入患者造影剂肾病的预防作用研究[J].慢性病学杂志,2013,(02):148-149.
点击复制

口服联合静脉补液对冠状动脉介入患者造影剂肾病的预防作用研究(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2013年02期
页码:
148-149
栏目:
经验交流
出版日期:
2013-02-28

文章信息/Info

Title:
-
作者:
王大强
南阳医专第一附属医院心内科,河南 南阳 473000
Author(s):
-
关键词:
口服联合静脉补液;  冠状动脉介入;  造影剂肾病
Keywords:
-
分类号:
R541.4
DOI:
-
摘要:
-
Abstract:
-

参考文献/References:

[1] Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency[J].Am J Kidney Dis,2002,39(5):930-936.
[2] Thomsen HS.European Society of Urogenital Radiology(ESUR)guidelines on the safe use of iodinated contrast media[J].Eur J Radiol,2006,60(3):307-313.
[3] Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal Failure after percutaneous coronary intervention[J].Circulation,2002,105(19):2259-2264.
[4] Solomon RJ,Mehran R,Natarajan MK,et al.Contrast-induced nephropathy and long-term adverse events: cause and effect[J].Clin J Am Soc Nephrol,2009,4(7):1162-1169.
[5] 郑华,屠燕,马立勤.冠心病患者经皮冠状动脉介入术后并发造影剂肾病的危险因素分析及防治策略探讨[J].南方医科大学学报,2011,31(7):1273-1276.
[6] Wright RS,Anderson JL,Adams CD,et al.2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction:a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines[J].Circulation,2011,123:2022-2060.
[7] 李华珍,汪红,梁文武.冠状动脉介入术导致对比剂肾病危险因素分析[J].中国动脉硬化杂志,2011,19(6): 529-532.

备注/Memo

备注/Memo:
作者简介:王大强,硕士,主治医师,主要从事冠心病的基础和临床研究工作 通讯作者:王大强,E-mail:wangdaqiang760525@163.com
更新日期/Last Update: 2014-07-08